UPC
Universe Pharmaceuticals Inc
NASDAQ: UPC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$3.21
-0.60% today
Updated 2026-05-01
Market cap
$1.74M
P/E ratio
—
P/S ratio
0.10x
EPS (TTM)
$-8.06
Dividend yield
—
52W range
$2 – $11
Volume
0.0M
Universe Pharmaceuticals Inc (UPC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.46M | $13.20M | $6.12M | $-2.06M | $-1.31M | $1.12M | $-9.51M | $-5.05M |
| Capital expenditures | $145095.00 | $86324.00 | $51798.00 | $13.53M | $93703.00 | $44172.00 | $363089.00 | $347187.00 |
| Depreciation | $452733.00 | $418431.00 | $410079.00 | $446878.00 | $533949.00 | $508785.00 | $485734.00 | $517431.00 |
| Stock-based comp | — | — | — | — | — | — | — | — |
| Free cash flow | $4.31M | $13.12M | $6.06M | $-15.59M | $-1.41M | $1.08M | $-9.87M | $-5.40M |
| Investing cash flow | $-145095.00 | $-86033.00 | $-51798.00 | $-27.06M | $-3.91M | $-44169.00 | — | $-341807.00 |
| Financing cash flow | $-4.91M | $-16.00M | $470136.00 | $26.58M | $3.32M | $-1.39M | $33.95M | $9.73M |
| Dividends paid | $3.06M | $16.00M | $0.00 | $0.00 | $0.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |